Frontiers in cellular and infection microbiology · 2025
Genomic epidemiological analysis reveals new insights into the resurgence of Mycoplasma pneumoniae in China.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wang Xue, Zheng Dandan, Gong Cheng, Luo Ming, Li Aihua, Duan Xuecong, Wang Chengcheng, Hu Geng, Guan Xuejiao, Yang Fan, Huang Fang, Chen Lihong
Аннотация
OBJECTIVES: After coronavirus disease 2019 pandemic restrictions, Mycoplasma pneumoniae (M. pneumoniae) re-surged widely across the world. This study aimed to determine the genomic epidemiological characteristics of resurging M. pneumoniae, which has dominated the respiratory infection outbreak in Beijing, China, since mid-September 2023.
METHODS: M. pneumoniae samples were collected from patients with acute respiratory-tract infections in Beijing in 2018-2023. A total of 160 M. pneumoniae genomes were sequenced via probe-capture-based approach. The genetic features of M. pneumoniae were characterized by multilocus sequence typing and comparative genomic analysis.
RESULTS: In total, 160 patients with M. pneumoniae infections were enrolled. ST3 (n = 93) and ST14 (n = 65) were the predominant sequence types. The macrolide-resistant mutation rate of ST3 was maintained at 100%, whereas that of ST14 increased rapidly. Comparative genomic analysis revealed 99% to > 99% similarity among the Beijing strains from 2023 when aligned to the reference M129 genome. The major variation occurs in the P1 gene. MAUVE indicated a lack of rearrangement, yet it included four subtype-specific insertions and non-conserved hsdS genes. The phylogenetic tree showed that strains from Asia and other world regions clustered into distinct clades, with significant evolutionary differences. Further genomic analyses identified some Asia-dominant genetic variations in genes associated with genome stability, pathogenesis, and drug resistance.
CONCLUSIONS: The 2023 outbreak of M. pneumoniae was not attributable to a novel variant but stemmed from the resurgence of the pre-existing strains. Our genomic epidemiological findings demonstrated that the endemic strains in different regions exhibit distinct genomic characteristics, associated with genomic stability.
METHODS: M. pneumoniae samples were collected from patients with acute respiratory-tract infections in Beijing in 2018-2023. A total of 160 M. pneumoniae genomes were sequenced via probe-capture-based approach. The genetic features of M. pneumoniae were characterized by multilocus sequence typing and comparative genomic analysis.
RESULTS: In total, 160 patients with M. pneumoniae infections were enrolled. ST3 (n = 93) and ST14 (n = 65) were the predominant sequence types. The macrolide-resistant mutation rate of ST3 was maintained at 100%, whereas that of ST14 increased rapidly. Comparative genomic analysis revealed 99% to > 99% similarity among the Beijing strains from 2023 when aligned to the reference M129 genome. The major variation occurs in the P1 gene. MAUVE indicated a lack of rearrangement, yet it included four subtype-specific insertions and non-conserved hsdS genes. The phylogenetic tree showed that strains from Asia and other world regions clustered into distinct clades, with significant evolutionary differences. Further genomic analyses identified some Asia-dominant genetic variations in genes associated with genome stability, pathogenesis, and drug resistance.
CONCLUSIONS: The 2023 outbreak of M. pneumoniae was not attributable to a novel variant but stemmed from the resurgence of the pre-existing strains. Our genomic epidemiological findings demonstrated that the endemic strains in different regions exhibit distinct genomic characteristics, associated with genomic stability.